Drug
Tl011
Tl011: highest development phase Phase 1, developed by Teva. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Teva
Trials
| Drug | Phase | Indication |
|---|---|---|
| TL011 NCT01205737 | Phase 1 | DLBCL |
Latest
No recent events.
Follow Tl011 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.